switch to a different analgesic now that propoxyphene (Darvon, etc) is off the market due to safety concerns

January 2011

Many patients will need to switch to a different analgesic now that propoxyphene (Darvon, etc) is off the market due to safety concerns.

Many experts say it's about time.

Propoxyphene can increase the risk of arrhythmias...even at usual doses and in patients without cardiac problems.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote